info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Sciatica Market Share

ID: MRFR//3341-HCR | 110 Pages | Author: Rahul Gotadki| December 2024

Better financial support is becoming available for alternative medicine treatments like acupuncture, presenting a significant opportunity for the market's growth. This increase in funding has been quite noticeable when we look back at previous years. To illustrate, back in October 2004, the National Center for Complementary and Alternative Medicine (NCCAM) granted 9.5 million dollars for research on acupuncture and Traditional Chinese Medicine (TCM). Now, let's fast forward to 2014 when the National Institutes of Health (NIH) reported a substantial leap in funding for complementary and alternative medicine, estimated to be around a massive 367.15 million dollars.

Moreover, the recent years have shown a promising surge in financial support specifically dedicated to acupuncture research. This surge in funding holds the promise of contributing significantly to the growth of the market. For instance, in 2016, the Vermont Legislature allocated a substantial sum of 200,000 dollars specifically to conduct a pilot study. This study aimed to evaluate acupuncture's effectiveness as an additional therapy for chronic pain among people covered by Vermont Medicaid.

The steady increase in financial support for acupuncture research demonstrates a growing interest and belief in its potential benefits. This kind of backing is crucial as it allows for more research and studies, which in turn helps us better understand how acupuncture works and its effectiveness in treating various health issues.

The increased funding in recent years has opened up new avenues for investigating the effectiveness of acupuncture as a complementary therapy. It allows researchers and practitioners to delve deeper into the mechanisms behind acupuncture's positive effects on health conditions, especially chronic pain management.

This financial backing has encouraged scientists, healthcare providers, and policymakers to explore and invest more in acupuncture research. It's providing an opportunity to conduct more comprehensive studies, which will help ascertain the effectiveness of acupuncture across various health conditions. This not only benefits patients by potentially offering more effective treatment options but also adds to the overall knowledge and acceptance of acupuncture in the medical community.

The allocation of substantial funds for specific studies and research projects is a clear indicator of the growing confidence in acupuncture's potential as a valuable therapy. It also encourages a collaborative effort among experts in the field, paving the way for more insightful and groundbreaking discoveries regarding the applications and effectiveness of acupuncture in healthcare.

This financial boost is a significant turning point, marking a shift towards recognizing acupuncture as a credible and worthwhile treatment option. It is hoped that such funding trends will continue to grow, fostering more in-depth research and paving the way for acupuncture to become more integrated into conventional healthcare systems.

Covered Aspects:

Report Attribute/Metric Details
Growth Rate 9.9% (2024-2030)

Global Sciatica Market Overview


Sciatica Market Size was valued at USD 15.21 Billion in 2023. The Global Sciatica industry is projected to grow from USD 15.73 Billion in 2024 to USD 19.86 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.59% during the forecast period (2024 - 2032).Sciatica is characterized by pain going down the leg from the lower back due to irritation of the lumbar or sacral nerves. Sciatica is triggered by activities like heavy lifting and jerky movements. However the condition can also develop gradually.

Global Sciatica Market

Typically, sciatica symptoms occur on one side of the body although in some cases the pain can be on both sides. The other symptoms of sciatica are weakness or numbness in the affected leg, burning or tingling down the affected leg, and constant pain on one side of the rear. The causes of sciatica are spondylolisthesis, muscle spasm in the back or buttock, spinal stenosis, piriformis syndrome, pelvic tumours, pregnancy and others. However, spinal disc herniation is the primary cause of sciatica in about 90% of the cases. Other uncommon causes are lumbar degenerative disc disease, osteophytes and arthritis of the spine.

Sciatica generally resolves on its own in about 90% of the cases. However it can result in severe pain which may need surgical intervention. Surgery may be required if complications occur such as bowel or bladder problems. Sciatica affects 40% of people at some point in their life time. Sciatica is most common during people's 40s and 50s, and men are more frequently affected than women.

The market drivers for global sciatica market are rise in demand due to growing population, increasing screening, rising cases of geriatrics, rising safety and success of drug treatment, the extricating nature of the pain and others. The market restraints are the complications of surgery such as risk of bleeding, infections, pain, high cost of sciatica treatment, and others.

Figure 1   Global Sciatica Market by Drug Treatment, 2016 (%) Global Sciatica Market


Sciatica Market Segmentation


The global sciatica market has been segmented on the basis of types, drug treatment, devices and end user.


Based on the types, the sciatica market has been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root sciatica and others.


Based on the drugs, the market has been segmented as anesthetics, pain killers, muscle relaxants, antidepressants, steroids and others.


Based on the non-drug treatment, the market has been segmented as physiotherapy, acupuncture, stimulation devices, surgery and others.


Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.


Sciatica Market Regional Analysis


The Americas accounts for a significant sciatica market share owing to high expenditure on the healthcare especially of the U.S. and Canada. Additionally, greater number of orthopedic procedures due to greater healthcare penetration in the U.S. and Canada drives the sciatica market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgical procedures especially the sciatica treatment in the returns of hospitals favors the market. A large number of medical devices companies in the U.S. is also a cause for the faster development of sciatica market in the US.


Europe is the second largest market in the world due to the growing medical devices industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry.


Asia Pacific region is expected to grow rapidly where China and India are likely to lead the market due to faster growing healthcare sector and larger unmet needs over the forecast period. The South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future sciatica market in the region.


Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle Eastern nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.


Key Players in the Global Sciatica Market


Some of the key players profiled in the report are 



  • Endo Pharmaceuticals, 

  • AstraZeneca, 

  • Novartis AG, 

  • Teva Pharmaceutical Industries

  • Neurotech, 

  • Nidd Valley Medical, 

  • Omega Laser Systems Ltd., 

  • Omron Healthcare, Inc., 

  • Sanofi 

  • and others.

  • Research Methodology Sciatica Market


Sources: Mayo Clinic, Healthline Media, MRFR Analysis


Intended Audience



  • Global Sciatica manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.